葡萄糖和山梨醇作为持续静脉输注肝素的稀释剂。
Dextrose and sorbitol as diluents for continuous intravenous heparin infusion.
作者信息
Chessells J M, Braithwaite T A, Chamberlain D A
出版信息
Br Med J. 1972 Apr 8;2(5805):81-2. doi: 10.1136/bmj.2.5805.81.
Abstract
A comparison of 5% dextrose and 5% sorbitol as diluents for heparin given by continuous intravenous infusion indicated that neither impaired the potency of the heparin. Previous suggestions that heparin becomes unstable in dextrose solution have not been confirmed.
摘要
对5%葡萄糖和5%山梨醇作为肝素持续静脉输注稀释剂的比较表明，两者均未损害肝素的效力。先前关于肝素在葡萄糖溶液中会变得不稳定的说法尚未得到证实。
相似文献
1
Dextrose and sorbitol as diluents for continuous intravenous heparin infusion.葡萄糖和山梨醇作为持续静脉输注肝素的稀释剂。
Br Med J. 1972 Apr 8;2(5805):81-2. doi: 10.1136/bmj.2.5805.81.
2
Intravenous infusions of heparin and penicillins.静脉输注肝素和青霉素。
J Clin Pathol. 1973 Oct;26(10):742-6. doi: 10.1136/jcp.26.10.742.
3
Heparin stability: effects of diluent, heparin activity, container, and pH.肝素稳定性：稀释剂、肝素活性、容器及pH值的影响
J Clin Pathol. 1980 Dec;33(12):1206-11. doi: 10.1136/jcp.33.12.1206.
4
Heparin stability in dextrose solutions [proceedings].葡萄糖溶液中肝素的稳定性[会议论文集]
J Pharm Pharmacol. 1977 Dec;29 Suppl:31P. doi: 10.1111/j.2042-7158.1977.tb11499.x.
5
Heparin elimination following continuous infusion during intra-aortic balloon counterpulsation.主动脉内球囊反搏期间持续输注后肝素的清除
Cathet Cardiovasc Diagn. 1985;11(4):389-92. doi: 10.1002/ccd.1810110406.
6
Pharmacokinetics of heparin. II. Studies of time dependence in rats.肝素的药代动力学。II. 大鼠体内时间依赖性研究。
J Pharmacol Exp Ther. 1979 Aug;210(2):243-6.
7
Compatibility and stability of diazepam injection following dilution with intravenous fluids.地西泮注射液用静脉输液稀释后的配伍性与稳定性。
Am J Hosp Pharm. 1978 Jun;35(6):669-72.
8
Management of heparin therapy: Controlled prospective trial.肝素治疗的管理：对照前瞻性试验。
N Engl J Med. 1975 May 15;292(20):1046-50. doi: 10.1056/NEJM197505152922002.
9
Laboratory control of continuous intravenous heparin therapy with Howel time and activated partial thromboplastin time. A prospective, randomized and blind study.采用豪厄尔时间和活化部分凝血活酶时间对持续静脉肝素治疗进行实验室控制。一项前瞻性、随机和盲法研究。
Angiology. 1985 Jun;36(6):363-9. doi: 10.1177/000331978503600605.
10
The stability of amoxycillin sodium in intravenous infusion fluids.阿莫西林钠在静脉输液中的稳定性。
J Clin Hosp Pharm. 1982 Dec;7(4):245-50. doi: 10.1111/j.1365-2710.1982.tb01029.x.
引用本文的文献
1
Heparin stability: effects of diluent, heparin activity, container, and pH.肝素稳定性：稀释剂、肝素活性、容器及pH值的影响
J Clin Pathol. 1980 Dec;33(12):1206-11. doi: 10.1136/jcp.33.12.1206.
2
Letter: Streptokinase and heparin in treatment of pulmonary embolism.信函：链激酶与肝素治疗肺栓塞
Br Med J. 1974 Jun 15;2(5919):610. doi: 10.1136/bmj.2.5919.610-b.
3
Intravenous infusions of heparin and penicillins.静脉输注肝素和青霉素。
J Clin Pathol. 1973 Oct;26(10):742-6. doi: 10.1136/jcp.26.10.742.
4
Anticoagulant activity of heparin in intravenous fluids.肝素在静脉输液中的抗凝活性。
J Clin Pathol. 1975 Jun;28(6):494-7. doi: 10.1136/jcp.28.6.494.
5
Antithrombotic drugs: part I.抗血栓药物：第一部分。
Drugs. 1976;12(1):41-68. doi: 10.2165/00003495-197612010-00002.
本文引用的文献
1
STABILITY OF HEPARIN SOLUTIONS.肝素溶液的稳定性
J Pharm Pharmacol. 1964 Jul;16:487-9. doi: 10.1111/j.2042-7158.1964.tb07498.x.
2
Heparin administration by constant infusion pump.使用恒速输液泵输注肝素。
Br Med J. 1967 May 20;2(5550):482-4. doi: 10.1136/bmj.2.5550.482.
3
Modern drug treatment and potential hazards to health.现代药物治疗与对健康的潜在危害。
Scott Med J. 1971 Aug;16(8):350-6. doi: 10.1177/003693307101600804.
4
Heparin in acid solutions.酸性溶液中的肝素。
Br Med J. 1971 Jul 31;3(5769):307. doi: 10.1136/bmj.3.5769.307-b.
5
The activated partial thromboplastin time in the control of heparin treatment.肝素治疗监测中的活化部分凝血活酶时间。
Australas Ann Med. 1970 Nov;19(4):334-7. doi: 10.1111/imj.1970.19.4.334.
6
Heparin requirements in patients with acute myocardial infarction.急性心肌梗死患者的肝素需求量
Arch Intern Med. 1970 Dec;126(6):1000-3.
7
Control of heparin therapy.肝素治疗的控制
Br Med J. 1970 Oct 17;4(5728):139-41. doi: 10.1136/bmj.4.5728.139.
8
Portable heparin injector.便携式肝素注射器。
Lancet. 1970 Sep 5;2(7671):521. doi: 10.1016/s0140-6736(70)90139-x.
Zotero 插件